Cf Therapeutics Development Network is a Medical Research business in Seattle, WA.
| Business Name: | Cf Therapeutics Development Network |
| Categorized In: | Medical Research |
| Address: | 1100 Olive Way # 500, Seattle, WA 98101 |
| Phone Number: | (206) 987-7800 |
| Contact Person: | Raissa Schneider |
| NAICS Code: | 541720 |
| SIC Code: | 8733 |
| Business Type: | B2B (Business to Business) |
| Founding Year: | 2006 |
| Employee #: | 1 to 4 |
| Location Type: | Single Location |
| Annual Revenue ($): | $100.000 to $499.999 |
| Share This Business: | |
| Similar Businesses: |
Denise Boudreau - Seattle, WA 98101 Accentus Medical - Seattle, WA 98101 Cystic Fibrosis WA State Chptr - Seattle, WA 98101 Benaroya Research Inst At VA - Seattle, WA 98101 Sibcr - Seattle, WA 98101 Seattle Institute For Biomedical And Clinical Research - Seattle, WA 98101 Pope L Moseley - Seattle, WA 98101 Quorum Review, Inc - Seattle, WA 98101 Intertox Inc - Seattle, WA 98101 Beneroy Medical Institute - Seattle, WA 98101 |
Cf Therapeutics Development Network, a stable growing company under Medical Research, is being run by Raissa Schneider. Since , their sales have been favorable and consistent at $100.000 to $499.999. Company location coordinates are: .
It can be reached by dialing (206) 987-7800, and you could get in touch with their sales team in 1100 Olive Way # 500, Seattle, Washington WA 98101. Visit their website at: to know more about the company’s history, products and services, as well as frequently asked questions and privacy policies.
Special deals are also offered from time to time. Their professional and honest business transactions fortifies both consumers and businesses in their B2B segments.
Their modest but solid single location houses 1 to 4 staff members. All are benefiting from the company’s generous programs and sound training solutions.
You can learn more by checking their classification codes: SIC – 8733 and NAIC – 541720. Call the hotline stated above for faster transaction and queries. Cf Therapeutics Development Network would like to hear from you.